Author

Isabell Wolf

Helmholtz-Zentrum Dresden-Rossendorf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexander Arthur WurmiD· 1 shared Anna Klimova· 1 shared Attila Jády· 1 shared Benjamin Christopher SchmidtiD· 1 shared Christoph E. HeiligiD· 1 shared Christoph HeiningiD· 1 shared Claudia Dagostino· 1 shared Claudia R. BalliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander Arthur WurmORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumors

Jasmina Paluncic, Zunamys Itzell Carrero, Lilly KS Fischer, Juliana P Schulz, Dorothea Hanf, Attila Jády, Fatima GutierrezTenorio, Anna Klimova, Claudia Dagostino, Isabell Wolf, Melanie Hüther, Maximilian Werner, Parham Pourabbas Tahvildari, Sara Hrabovska, Maria G Santos, , Claudia R. Ball

This study develops an ex vivo drug sensitivity testing platform for rare solid tumors and finds that high in vitro sensitivity correlates with clinical benefit and progression-free survival.

bioRxiv · Feb 19, 2026 · PreprintCancer Biology